Topikal Retinoidler: Retinol, retinaldehit, retinil esterleri

Riahi RR, Bush AE, Cohen PR. Topical retinoids: therapeutic mechanisms in the treatment of photodamaged skin. Am J Clin Dermatol. 2016;17(3):265-276.

Li W, Liu Y, Luo Q, Xue-Mei L, Xi-Bao Z. Off-label uses of retinoids in dermatology. Our Dermatology Online. 2012; 3:259.

Shao Y, He T, Fisher GJ, Voorhees JJ, Quan T. Molecular basis of retinol anti-ageing properties in naturally aged human skin in vivo. Int J Cosmet Sci. 2017;39(1):56-65.

Rittié L, Varani J, Kang S, Voorhees JJ, Fisher GJ. Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. J Invest Dermatol. 2006;126(4):732-739.

Varani J, Warner RL, Gharaee-Kermani M, Phan SH, Kang S, Chung J, et al. Vitamin a antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol. 2000;114(3):480-486.

Kawada A, Konishi N, Momma T, Oiso N, Kawara S. Evaluation of anti‐wrinkle effects of a novel cosmetic containing retinol using the guideline of the Japan Cosmetic Industry Association. J Dermatol. 2009;36(11):583-586.

Sorg O, Antille C, Kaya G, Saurat JH. Retinoids in cosmeceuticals. Dermatol Ther. 2006;19(5):289-296.

Serri R, Iorizzo M. Cosmeceuticals: focus on topical retinoids in photoaging. Clin Dermatol. 2008;26(6):633-635.

Antille C, Tran C, Sorg O, Carraux P, Didierjean L, Saurat JH. Vitamin A exerts a photoprotective action in skin by absorbing ultraviolet B radiation. J Invest Dermatol. 2003;121(5):1163-1167.

Pechere M, Germanier L, Siegenthaler G, Pechère JC, Saurat JH. The antibacterial activity of topical retinoids: the case of retinaldehyde. Dermatology. 2002;205(2):153-158.

Pechere M, Saurat JH. Antibacterial activity of retinaldehyde against Propionibacterium acnes. Dermatology. 1999;199(Suppl. 1):29-31.

Sorg O, Kuenzli S, Kaya G, Saurat JH. Proposed mechanisms of action for retinoid derivatives in the treatment of skin aging. J Cosmet Dermatol. 2005;4(4):237-244.

Griffiths CEM, Finkel LJ, Ditre CM, Hamilton TA, Ellis CN, Voorhees JJ. Topical tretinoin (retinoic acid) improves melasma. A vehicle‐controlled, clinical trial. Br J Dermatol. 1993;129(4):415-421.

Sorg O, Saurat JH. Topical retinoids in skin ageing: a focused update with reference to sun-induced epidermal vitamin A deficiency. Dermatology. 2014;228(4):314-325.

Gans LH, Kligman EH. Re-emergence of topical retinol in dermatology. J Dermatolog Treat. 2000;11(1):47-52.

Saurat JH. Skin, sun, and vitamin A: from aging to cancer. J Dermatol. 2001;28(11):595-598.

Sachsenberg-Studer EM. Tolerance of topical retinaldehyde in humans. Dermatology. 1999;199(Suppl.1):61-63.

Tanghetti EA, Popp KF. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization. Dermatol Clin. 2009;27(1):17-24.

Ries G, Hess R. Retinol: Safety considerations for its use in cosmetic products. Cutan Ocul Toxicol. 1999;18(3):169-185.

Creidi P, Vienne MP, Ochonisky S, Lauze C, Turlier V, Lagarde JM, et al. Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment. J Am Acad Dermatol. 1998; 39:960-965.

Boisnic S, Branchet-Gumila MC, Nocera T. Comparative study of the anti-aging effect of retinaldehyde alone or associated with pretocopheryl in a surviving human skin model, submitted to ultraviolet A and B irradiation. Int J Tissue React. 2005: 27: 91-99.

Poli F, Ribet V, Lauze C, Adhoute H, Morinet P. Efficacy and Safety of 0.1% Retinaldehyde/6% Glycolic Acid (Diacnéal®) for Mild to Moderate Acne vulgaris. Dermatology. 2005;210(Suppl.1):14-21.

Dréno B, Nocera T, Verrière F, Vienne MP, Ségard C, Vitse S, et al. Topical retinaldehyde with glycolic acid: study of tolerance and acceptability in association with anti-acne treatments in 1,709 patients. Dermatology. 2005;210(Suppl.1):22-29.

Dreno B, Katsambas A, Pelfini C, Plantier D, Jancovici E, Ribet V, et al. Combined 0.1% retinaldehyde/6% glycolic acid cream in prophylaxis and treatment of acne scarring. Dermatology. 2007;214(3):260-267.

Katsambas AD. RALGA (Diacnéal®), a Retinaldehyde and Glycolic Acid Association and Postinflammatory Hyperpigmentation in Acne–A Review. Dermatology. 2005;210(Suppl. 1):39-45.

Morel P, Vienne MP, Beylot C, Bonerandi JJ, Dreno B, Lehucher-Ceyrac D, et al. Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris. Clin Exp Dermatol. 1999;24(5):354-357.

Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol. 1975;111(1):40-48.

Herndon Jr JH, Jiang LI, Kononov T, Fox T. An Open Label Clinical Trial to Evaluate the Efficacy and Tolerance of a Retinol and Vitamin C Facial Regimen in Women with Mild-to-Moderate Hyperpigmentation and Photodamaged Facial Skin. J Drugs Dermatol. 2016;15(4):476-482.

Grimes PE. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation. Cutis. 2004;74(6):362-368.

Draelos ZD. Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream. Dermatol Surg. 2005; 31:799-805.

Türsen Ü. Deri yaşlanmasının topikal ajanlarla önlenmesi. Dermatoz. 2006; 4:267-283.

Ho ET, Trookman NS, Sperber BR, Rizer RL, Spindler R, Sonti S, et al. A randomized, double-blind, controlled comparative trial of the anti-aging properties of non-prescription tri-retinol 1.1% vs. prescription tretinoin 0.025%. J Drugs Dermatol. 2012;11(1):64-69.

Kong R, Cui Y, Fisher GJ, Wang X, Chen Y, Schneider LM, et al. A comparative study of the effects of retinol and retinoic acid on histological, molecular, and clinical properties of human skin. J Cosmet Dermatol. 2016;15(1):49-57.

Karadag AS, Aksoy B, Parish LC. The Background of Retinoids. In Retinoids in Dermatology 2019;(pp. 1-2). CRC Press.

Fluhr JW, Vienne MP, Lauze C, Dupuy P, Gehring W, Gloor M. Tolerance profile of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions. Dermatology. 1999;199(Suppl. 1):57-60.

Thielitz A, Abdel‐Naser MB, Fluhr JW, Zouboulis CC, Gollnick H. Topical retinoids in acne–an evidence‐based overview. J Dtsch Dermatol Ges. 2008;6(12):1023-1031.

Culp L, Moradi Tuchayi S, Alinia H, Feldman SR. Tolerability of topical retinoids: are there clinically meaningful differences among topical retinoids? J Cutan Med Surg. 2015;19(6):530-538.

Williams AL, Pace ND, DeSesso JM. Teratogen update: Topical use and third‐generation retinoids. Birth Defects Res. 2020;112(15):1105-1114.

Veraldi S, Rossi LC, Barbareschi M. Are topical retinoids teratogenic? G Ital Dermatol Venereol. 2016;151(6):700-705.

Han G, Wu JJ, Del Rosso JQ. Use of Topical Tazarotene for the Treatment of Acne Vulgaris in Pregnancy: A Literature Review. J Clin Aesthet Dermatol. 2020;13(9): E59.

Doğan B, Karabudak Ö. Gebelik ve Laktasyonda Dermatolojik İlaç Kullanımı. Turkderm. 2007;41(Supp: 1):8-12.

Yıldız H, Abuaf ÖK. Gebelik ve emzirme döneminde kozmesötik kullanımı. Turkderm. 2013; 47:194-9.

Bedi MK, Shenefelt PD. Herbal therapy in dermatology. Arch Dermatol. 2002; 138:232-242.

Nordeng H, Havnen GC. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiol Drug Saf. 2004; 13:371-80.

Van De Kerkhof PC. Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology. Dermatol Ther. 2006;19(5):252-263.

Aranegui B, García-Cruz A. Topical retinoids. In Dermatological Treatments. Bentham Science Publishers EAU. 2012;(p. 130).